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Available online xxxxBackground: The absence ofmenstruation is common inwomenwho use drugs. This can give a belief that conception is
unlikely. When stabilised on Opioid Substitution Treatment (OST), fertility often returns, initially without realisation
as ovulation precedes menstruation. This leaves women vulnerable to unplanned pregnancies. Community pharma-
cists (CPs) are frequently in contact with this patient group through the Supervised Consumption of OST service.
This provides a timely opportunity to provide reproductive health (RH) advice. The aim of this studywas to investigate
pharmacists' views on providing a RH service to women receiving OST.
Methods: Twenty semi-structured interviews based on the Capability-Opportunity-Motivation to Behaviour (COM-B)
model and the Theoretical Domains Framework (TDF) were conducted between 2016 and 2017. Data analysis in-
volved deductive coding using the TDF domains. The TDF domains were mapped onto the elements of the COM-B
and used in the second step to create the framework and chart the data. The third step involved re-reading and clus-
tering the codes, and inductive themes were generated to explain the data in depth.
Results:Nine of the 14 TDF domains, mapped into five elements of the COM-B, were identified. Five inductive themes
were generated: 1) The pharmacists' experience and knowledge of reproductive health (RH) needs of women receiving
OST, 2) The pharmacists' approach to providing advice, 3) The pharmacists' perception of the relationshipwithwomen
receiving OST, 4) Social influences, and 5) Environmental factors. Community pharmacists feared causing offense to
women receiving OST and described requiring cues as to when the service was needed. Pharmacists' highlighted a
power imbalance in the relationship with women receiving OST. This could influence how receptive this patient
group would be to pharmacy RH interventions.
Conclusions: CPs' concerns of providing RH service could hinder a proactive service provision. Supporting good rapport







Health services for women1. Introduction
In the UK, community pharmacists often supervise the consumption of
Opioid Substitution Therapy (OST) (e.g. methadone, buprenorphine) in
their pharmacies, especially in the early stage of opioid use disorder
treatment.,1,2 This supervised consumption service (SC)3 provides the
service user with regular contact with a health care professional (theervised Consumption service; RH, Rep
Change Wheel; COM-B, Capability-Op
niversity of Bristol, Bristol, UK.
in), J.A.Scott@bath.ac.uk (J. Scott), jo
er Inc. This is an open access articpharmacist), more frequently than others involved in their care. In this con-
text, the Department of Health described that role as “providing an opportu-
nity for the pharmacist to build a therapeutic relationship with the patient that is
beneficial to promote health and harm reduction, (p.102)”.4 However, little re-
search has been conducted to illustrate how pharmacists contribute to the
general wellbeing of SC patients.5roductive Health; CPs, Community pharmacists; LARC, Long-Acting Reversible Contraceptives;
portunity-Motivation to Behaviour model; TDF, Theoretical Domains Framework.
anne.neale@kcl.ac.uk (J. Neale), angel.chater@beds.ac.uk (A. Charter),
le under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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cantly compromised compared to those from the general public.6–9 For ex-
ample, 35% of women who receive OST use contraception compared to
75% of those in the general population.6–8 Additionally, a retrospective co-
hort study found that women receiving OST have an age-matched termina-
tion rate of 0.46 per woman vs 0.025 for the general population.7 Poor diet,
weight loss, amenorrhea and anovulation are common in women who are
addicted to opioids.9 The absence of menstruation can lead women to be-
lieve they are unable to conceive.9 However, when stabilised on OST,
their fertility often returns without their realisation because ovulation pre-
cedesmenstruation.6,10 This leaves women receiving OST vulnerable to un-
planned pregnancies which might have significant consequences on the
mother and child. The Department of Health recommends that community
drug teams and OST prescribers should provide contraception advice.11
However, this advice is not routinely given as fewer than 40% ofwomen at-
tending community drug teams in London reported discussing contracep-
tion with their drug worker or general practitioner.6
Public Health England strongly recommends the expansion of the CPs'
role in delivering sexual and reproductive health in general,4 as CPs are ac-
cessible to all including people living in deprived communities who often
face health inequalities. The recommendations include supplying oral con-
traception as well as ensuring referral for a timely provision of long-acting
reversible contraceptives (LARCs). Many pharmacies are already engaging
in providing services related to RH to the general public including emer-
gency hormonal contraception (EHC), Chlamydia screening and treatment,
pregnancy testing, condom distribution and sexual health promotion.12
The purpose of this studywas to explore the acceptability and feasibility
of the potential role expansion for CPs with a view to informing the design
of a future intervention to provide women receiving OSTwith reproductive
health (RH) service.2. Methods
A qualitative study using semi-structured interviews was undertaken.







Fig. 1. A flow chart illustrates the COM-B system and th
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COREQ (Consolidated criteria for reporting qualitative research) guidelines
for reporting qualitative research.13
2.1. Participant recruitment
Twenty community pharmacists (CPs) were recruited from pharmacies
across London and parts of the Southwest of England between September
2016 and May 2017.
The sample size was chosen to provide a medium sized sample for
Framework Analysis and one which was practical within the timeframe
for this study.14,15 Recruitment was opportunistic due to challenges in
recruiting CPs into research studies due toworkload and difficulties infind-
ing a locum cover. CPs were therefore offered a two-hour locum fee (£70)
to cover their practice time while participating in the study and as an ac-
knowledgement of participation.16,17 Their travel expenses were also paid
if they travelled to meet the researcher.
2.2. Materials
The topic guide development (and later the analysis) was informed by
the (COM-B) model,18 and the TDF (see Fig. 1),19,20 in consultation with
a Project Advisory Group (included clinicians and patient representatives).
Growing evidence supports the use of theory when understanding a behav-
iour. The COM-B model was designed to facilitate a behavioural diagnosis
by understanding six determinants of behaviour (psychological capability,
physical capability, automatic motivation, reflective motivation, social op-
portunity, and physical opportunity).18 This then is linked with interven-
tion strategies for behaviour change.18,21 The TDF is a framework
originally synthesised from 33 theories of behaviour and behaviour change
which draws together cognitive, affective (emotion), environmental and so-
cial influences on behaviour.19,20 The TDF was later mapped into the six el-
ements of the COM-B model as to give a more detailed insight to the target
behaviour (see Fig. 1).18,20,21 The target behaviour in our studywas the CPs'
provision of RH service to women receiving OST. This approach to inter-
vention development design is widely used,22 and has been used in previ-
ous research on contraception interventions.23,24 The topic guide coverede TDF domains, based on References 19 and 34.19,34
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OST. It also covered CPs' views on the design of a future RH service (Supple-
mentary file 1) The topic guide was piloted once and since no issues were
reported from the interviewee, the piloted interview was incorporated to
the study. In this paper, we report the first three topics covered in the
topic guide. Service design and training needs are reported separately in-
conjunction with data from women receiving OST as these describe the
next step of the intervention development.
2.3. Procedure for data collection
CPs received a study information pack through the post prior to the in-
terview date. At the start of the interview, CPs completed and returned their
written consent form. Interviews took place either by phone (n=5) or face-
to-face (n = 15) at a time and place of choice of the participant. No re-
peated interviews took place and transcribed interviews were not offered
to interviewees to check due to not having the time capacity to do so. Inter-
views were conducted and audio recorded by (NA), a post-doctoral female
pharmacist researcher, PhD, (17 interviews) and (HF), a female lecturer,
chartered psychologist and health psychology researcher, PhD, (three inter-
views). Both interviewers are trained qualitative interviewers. The research
team comprised researchers with backgrounds in health psychology ap-
plied to pharmacy (HF, AC), addiction science (JN, JS, NA), and pharmacy
(JS, NA).
2.4. Ethics
The study was reviewed and approved by the Greater Manchester West
Research Ethics Committee (REC Reference 16/NW/0376). Health Re-
search Authority approvals to conduct the research were given (IRAS Ref:
20049).
2.5. Analysis
The recorded semi-structured interviews were anonymously tran-
scribed verbatim, then analysed using NVivo qualitative data analysis soft-
ware (Version 11 (mac), QSR International, Melbourne, Australia). Data
were analysed using a combination of framework analysis,25,26 and the-
matic analysis.27 This enabled the identified themes, issues, or discussion
points to be explored in depth via thematic analysis while using the COM-
B model as an explanatory framework and to help build a future
intervention.28–33 The first step in the analysis involved NA reviewing the
transcripts through the stages of familiarization and deductively codingTable 1
Participant characteristics.
ID Age Gender Ethnicity Type of pharmacy
Pharm 1 50 Female White British Large multiple
Pharm 2 nd⁎ Male North African Large multiple
Pharm 3 nd⁎ Male White British Large multiple
Pharm 4 35 Male Black African Independent
Pharm 5 39 Male Any other white background Locum
Pharm 6 51 Male White British Large multiple
Pharm 7 36 Female Any other white background Independent
Pharm 8 36 Male Any other white background Independent
Pharm 9 38 Female White British Large chain
Pharm 10 31 Female Chinese Independent
Pharm 11 32 Female North African Large multiple
Pharm 12 35 Male Indian Independent
Pharm 13 33 Male Black British-African Independent healthy living p
Pharm 14 53 Male Black British-African Independent
Pharm 15 59 Male Black African Independent
Pharm 16 42 Male Black African Independent
Pharm 17 33 Female North African Independent
Pharm 18 27 Male Black British-African Large multiple
Pharm 19 32 Male Indian Independent healthy living p
Pharm 20 45 Male British Asian Independent
⁎ nd: no data.
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the transcripts using the 14 TDF domains. Inductive codes were also
added to capture key elements of the pharmacists' interviews which were
not adequately described by the TDF domains (e.g. CPs' past experience
of RH needs of women receiving OST, CPs' perception of the characteristics
of women receiving OST). NA coded all the transcripts. At the start of cod-
ing NA andHF coded two transcripts, codeswere compared, and discrepan-
cies discussed to ensure that coding to the TDFwas consistent. The next step
of the framework analysis involved charting the data and mapping the TDF
domains to the COM-Bmodel. The third step of analysis drew from the the-
matic analysis approach of Braun and Clarke,27 with the purpose of devel-
oping inductive themes that explained in depth pharmacists' views on
providing RH service to women receiving OST. This step was achieved by
re-reading, reviewing and clustering the identified TDF codes, the COM-B
constructs and the identified inductive codes to form inductive themes
and sub-themes, and then naming the themes.
3. Results
3.1. Demographics
Twenty community pharmacists (CPs) took part in the study, 10 from
London (n=2 female, n=8male), and 10 from the southwest of England
(n= 4 female, n= 6 male). The average age of the CPs was 39 ± 9 years
old (missing data for 2 CPs). Over half of the interviewees (n=12) worked
in independent pharmacies and there was one locum. Years of practice
ranged between 2.5 and 35 years and CPs originated from eight different
ethnicities. We asked the CPs how many female OST clients they currently
had, and it ranged between 1 and 12, with some CPs declining to answer.
Table 1 reports the participants' characteristics in detail. The average time
of the interviews was 70 ± 19 min.
3.2. TDF and COM-B behavioural diagnosis – determinants of the CPs' provision
of RH service to women receiving OST
Framework analysis led to the identification of nine of the 14 TDF do-
mains: knowledge; memory, attention and decision making; beliefs about
capabilities; beliefs about consequences; social /professional role and iden-
tity; emotion; reinforcement, social influences; environmental context and
resources. These domains were then mapped onto five elements of the
COM-B model: psychological capability; reflective motivation; automatic
motivation; social opportunity; and physical opportunity. Fig. 2 shows the
mapping process with the identified TDF domains and COM-B constructs
presented.Years of practice Number of women, attending the pharmacy
28 1 (and one recovered)
7 Between 50 and 60 clients, females' number is unknown
27 ~12
12 1 (and 2 recovered)
11 Depends on the pharmacy
12 7
12 ~10
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Fig. 2. Combined COM-B and TDF analysis of the determinants of the CPs' provision of RH service to women receiving OST.
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Fig. 3. Thematic map presenting the five inductive themes generated from the data. Each colour represents a theme and subthemes within that theme. The arrows represent
how these themes influence each other. The subthemes highlighted in green show the thought process of the CPs around providing RH advice. It starts with the CPs
responding to triggers (women asking), assessing the need for the service, then reflecting on their confidence and outcome expectancy of such service, balancing between
their own prejudices and their professional duties, and finally concluding that a structure is needed to provide the service. (For interpretation of the references to colour
in this figure legend, the reader is referred to the web version of this article.)
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Five themeswere inductively generated: 1) The pharmacists' experience
and knowledge of reproductive health (RH) needs ofwomen receivingOST,
2) The Pharmacists' approach to providing advice, 3) The pharmacists' per-
ception of the relationship withwomen receiving OST, 4) Social influences,
and 5) Environmental factors (see thematic map in Fig. 3).
These themes are presented below with the related COM-B constructs
and TDF domains underneath (shown in brackets (COM-B; [TDF])).
Anonymised quotations from CPs are presented, with their participant
number.
4. Theme 1. The pharmacists' experience and knowledge of
reproductive health (RH) needs of women receiving OST
(COM-B: Psychological Capability and Reflective Motivation; [TDF
domains: knowledge; Beliefs about consequence])
Many CPs had experience of providing OST for women who were preg-
nant (planned and unplanned) or who needed support with their reproduc-
tive health (RH) needs.
“She said “I seem to have put on weight but I am not eating more... she said
that she hadn't had a period and then I asked whether she had any sexual...
she can't remember... I offered her a pregnancy test... it came back positive”
CP. 2
“She was very happy and she was looking forward to having her baby and by
the time [of birth], she was off… she was not on methadone” CP. 12
Most CPs reported that they did not have enough knowledge about OST
effects on fertility [TDF: Knowledge]. Their advice usually would include to
take folic acid, maintain a healthy diet, stop smoking, avoid alcohol, and
being checked for sexually transmitted diseases (STD). Most CPs felt they5
would be able to talk about the different contraceptionmethods but felt un-
able to advise on the most suitable method for any given individual [TDF:
knowledge]. Some said they would recommend the use of long-acting re-
versible contraception (LARC; e.g. intrauterine device, contraceptive im-
plant, contraception injection) for this patient group, because women
receiving OST were perceived as likely to forget to take oral contraception
(‘the pill’) regularly [TDF: Beliefs about consequences].
“I know that probably oral contraception might not be umm a very efficient
method for her because she might forget to take… But err I think the one of
the implants or the intrauterine devices because they will be better suited for
her” CP. 2
Most CPs did not know whether women used contraception [TDF:
Knowledge] and they speculated that women must have had RH advice
from other health care professionals.
“I don't know whether they might have got implant or anything or getting pre-
scriptions for contraception I wouldn't know or if they go to family planning
clinics” CP. 13
5. Theme 2. The pharmacists' approach to providing advice
(COM-B: Psychological Capability, Reflective Motivation, Automatic Moti-
vation, Social Opportunity, Physical Opportunity; [TDF domains: knowledge,
memory, attention and decision making; Beliefs about capability; Beliefs about
consequence; emotions; social/professional role and identity; social influences;
environmental context and resources])
Most CPs indicated that they struggled with the concept of proactively
providing RH advice to every woman receiving OST. Some felt that a
woman should initiate the topic, or they needed an opportunity onto
which they could add the topic onto. The sub-themes below map out the
thought process that CPs discussed during the interview.
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Many CPs described their approach to provide health advice generally
as a response to triggers i.e. social triggers (the patient initiating the sub-
ject) [TDF: social influences] or physical triggers (an issue related to a pre-
scription) [TDF: environmental context and resources]. This response
(COM-B: automatic motivation) was motivated by the CPs' sense of their
professional role and identity as health care providers [TDF: social/profes-
sional role and identity].
“It's not something that's always in mymind to be honest… when I talk to pa-
tients it's probably when I see their medication history if they're taking some-
thing that would interact, but if I'm not aware that medication interact with
their pill, I wouldn't approach the subject unless they ask about it” CP. 11.
“I mean I'll always give them advice if they ask for it, but if they expect me to
just bring it out doesn't make any sense you need a trigger to initiate some-
thing” CP. 19.
5.2. Pharmacists' provision to RH advice proactively (pharmacists initiating the
topic)
When it was suggested that RH advice could be provided proactively
(without being asked for by patients), CPs reflected on different issues:
5.3. Assessing the need of the service
Some CPs articulated that the woman's need for this advice should be
assessed on an individual basis [TDF: memory, attention and decision pro-
cesses]. However, CPs also described assessing women's need for RH advice
as challenging because they often did not know the women's circumstances
e.g. whether they had a partner(s), were hoping to be pregnant now or in
the future, if they had contraception already or if they needed it [TDF:
Knowledge]. Several factors were seen as potential indicators for the need
for RH advice, e.g. age, involved in sex work, appearance, homelessness,
partners [TDF: Social influences].
“it would depend on need; we cannot give out this advice to everybody”CP. 15.“Researcher: when would you give this advice to women? CP:When I thought
it is needed. Researcher: when do you think it is needed? CP: So if I see if they
are sexually active if, this is regarding the methadone and the substance mis-
use patients yeah if I sense if I see them with different people all the time or
they have a regular partner still tell them” CP. 18.
5.4. CPs' confidence in providing the RH advice
CPs said their experience of training for and providing other similar ser-
vices (e.g. EHC, the flu vaccine) rendered them open to adopt this service
(with the right training) However, several CPs said they would feel less
competent in providing the advice to women receiving OST with compli-
cated medical cases, history of sexual abuse or struggling with mental
health [TDF: Beliefs about capabilities].
“If I felt that this conversation that I couldn't have a logical conversation with
the patient the patient was maybe one that had really badly managed psy-
chotic, err you know psychological conditions I don't want to feed into some-
thing that's going to create more problems for the patient. So I think it would
be the same reasons why I would not do that” CP. 4.“Such a personal thing” woman receiving OST might get offended.
CPs felt RH was a personal topic and they feared women receiving OST
might be offended or uncomfortable. This was even more of a concern for6
male pharmacists or locums (locums were aware that SC patients were
less comfortable with new faces). CPs worried that discussing RH may
raise difficult emotions e.g. difficulties in getting pregnant, sexual abuse,
and previous children taken into care. CPs sometimes described women
as being ‘angry’, ‘intimidating’, ‘closed down’ or ‘ashamed’ and explained
how this made conversations difficult. Conversely, other female OST pa-
tients were perceived as easier to talk to because they were ‘chatty’ or
friendly [TDF: Emotions, Beliefs about consequences].
“You know we have to be careful that we're not doing the one thing that the
patient doesn't want… [gives examples of what women might say if CPs
raised RH topic] “Are you having this conversation with me just because I
take methadone”” CP. 4.
“I think mine would be alright actually we have good chats anyway” CP. 9.
“They won't listen” Women receiving OST would not listen.
Some CPs questionedwhether the womanwould accept the advice. CPs
used expressions like “if they listen” or “if they understand”, “not going to be
receptive” or “if they're willing to discuss” to describe some the perceived pos-
sible reactions. Some CPs also highlighted a belief that women tend to gain
their health information from unreliable sources and not listen to health
care professionals [TDF: Beliefs about consequences].
“Some of them are just not very compliant wouldn't listen and so that's an-
other thing that would make me reluctant, so it goes on the character of the
patient” CP. 17.
5.5. Stigma? or moral responsibility?
CPs expressed worry and concerns [TDF: emotions] about the conse-
quences of the advice they might give. Some CPs were of the opinion that
for women who engaged in risky behaviours, pregnancy planning advice
was not appropriate as their risk behaviours could have adverse effects on
the developing child [TDF: Beliefs about consequences]. As a result, CPs
felt more at ease providing contraception advice.
“From a feeling point of view, umm, I suppose it is being much more aware of
their likelihood of risky behaviours and worrying what might or might not go
wrong as a result of your advice... that's in a way it is always in your subcon-
scious... Again, it is about helping them to make the right decisions for them-
selves and if they decide, whether it because of their own acknowledgement of
their own behaviours, that it is not right to have a baby or if they are wanting
support to not have a baby, then it is making sure they are getting the right
support in the right way I suppose” CP. 6.5.6. The structure
Many CPs suggested that the topic should be approached through a
structured consultation on wider lifestyle advice or medicines review, so
as to leave the choice to the women to ask for further advice or not.
“So, in order for me to bring such a topic umm it needs to have umm kind of
properly structured consultation… you are taking a full history … and then
patients see it as normal” CP. 2.
6. Theme 3: the pharmacists' perception of the relationship with
women receiving OST
(COM-B: Automatic Motivation, Social Opportunity; [TDF domains: social/
professional role and identity, emotions, social influences])
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ceiving OST was central to the patient accepting the pharmacist's interven-
tion.
“You have to have a close relationship to tell them, one girl that she was com-
ing a lot for the [emergency] oral contraception so I told her to go on the in-
jection and she is on the [contraception injection brand name] at the
moment” CP. 16.
The dynamics of this relationship seemed to be influenced by several
factors including the nature of the SC service (i.e., controlled, pharmacist
has the power to approve/not approve the administration), the patient
group characteristics (easy going vs difficult client) [TDF: social influ-
ences], and the pharmacists' perception of their professional role (involved
and empathetic, vs having boundaries) [TDF: social/professional role and
identity]. The interaction between these factors led to three characteristics
of this relationship including a relationship built on empathy and trust, a re-
lationship built on respect or that built on power.
6.1. Empathy and trust
Due to the regular contact between CPs and women receiving OST
(daily to weekly), CPs described developing good rapport with women
[TDF: emotions]. CPs talked about providing physical health care, social
support and keeping an eye on their wellbeing (e.g. reporting concerns
back to prescribers), [TDF: social/professional role and identity].
“One day when she lost the baby she was quite down she was on the floor
almost… The prescriber rang me she told me look they lost the baby… I saw
her she was red orange like she was about to explode I said: “I need to have a
chat with you”,[woman receiving OST who lost the child replying] “now I'm
not in the mood”,
[CP replying]: “yes you are”.and I brought her here in the consultation room
and we had a chat when she left I felt she was different. He came as well [the
partner] both of them were here I had 20min chat with them I had plenty of
customers here waiting for me but I said no I'm doing my job properly” CP.8
6.2. Respect
Many CPs regarded their patients as polite and with reasonable conduct
and in most cases like any other patient populations. CPs also mentioned
the importance of treating patients with respect, to preserve their confiden-
tiality and dignity [TDF: Social/professional role and identity].
”I accord them respect, I greet them by their name I serve them as promptly as
I can ummand some of them have been with me for a number of years so they
don't come to me because I am the nearest the most convenient in fact further
from the truth they come to me because they are accorded good friendly
service“CP. 15.
6.3. Power
Other CPs described having to exhibit authority over this patient popu-
lation. Partly, because of the legalities of the SC service where pharmacists
had to ensure the patient is taking the OST dose without diverting it [TDF:
Social / professional role and identity]. Another part was to control cases of
drunkenness, aggression and shoplifting [TDF: Social influences]. In one
case, one participant said that they had used extended waiting time as a
way of punishment for behaviour they deemed unacceptable (e.g.
pretending to take an OST dose). Some pharmacists also felt hurt and
offended when a patient receiving OST lied or were caught stealing from
the pharmacy [TDF: Emotion].7
“You need to be very firm, if they are drunk you say okay go and have a walk
and come back so they feel that you are protecting them, even though they
might not like it at that moment but they will come back to you and say oh
I am sorry about that yesterday and so they like that bit of authority when
you can be a bit, kind of umm, so that they know what you are doing is for
their own benefit” CP. 2.
“You kind of feel a bit hurt [with reference to shop lifting]” CP. 9.
“Because she lied to me and I don't like to be lied, and I kept her there to re-
member me…” CP. 7.
7. Theme 4: social influences
(COM-B: Social Opportunity, AutomaticMotivation; [TDF: social influences,
emotions])
CPs commented that they probably would not approach the subject of
RHwhenwomen receiving OSTwere accompanied e.g. by children or part-
ners [TDF: Social influences]. CPs felt it was hard to knowwhether partners
supported women with their RH needs or not and that the situation should
be assessed very carefully. Some CPs felt that providing SC services might
affect the business financially. They assumed that other customers (e.g.
older patients or those with children) might feel uncomfortable being
around some SC patients. Similar attitudeswere perceived regarding sexual
health services or advertising them in the pharmacy [TDF: social
influences].
“I don't promote it; I don't put a banner outside saying sexual health clinic be-
cause again I want to keep it as for image” CP. 19.
Some CPs stated that they felt pressure from the pharmacy support staff
not to take on more work or felt that pharmacy staff might question the
ethics of the service (stigma).CPs described these situations as leaving
them struggling to delegate and worried to leave the shop floor for long
[TDF: Emotion].
“CP: I think for the family planning side of things I think they [the staff]
might struggle a little bit with that but with the contraception thing no problem
at all. I think just they would worry they worry about children being brought
up in that type of environment.Researcher: How does that make you feel?CP:
I understand their concerns I do and sometimes you have them yourself but
then you kind of see how others [women receiving OST] cope with, it's almost
a split personality in a way that they've got their family life and then they've
got this other life [addiction] yeah so and then others you got it's their family
nearby who end up looking after a lot so you do see that as well” CP. 9.
8. Theme 5: environmental factors
(COM-B: Physical Opportunity, Reflective Motivation, Automatic Motiva-
tion; [TDF domain: environmental context and resources, beliefs about conse-
quences, social/professional role and identity, reinforcement])
8.1. Workload
Many CPs stated there was a need to have a second pharmacist to cover
other services while a service was taking place in the consultation room
[TDF: Environmental context and resources]. CPs highlighted the risk of
adding many services without freeing the pharmacist from other responsi-
bilities, as this could compromise safety [TDF: Beliefs about consequences].
Additional issues included the burden of paperwork, accessing the sum-
mary care record of the patient and having many women receiving OST.
In the latter instance, CPs with larger numbers of OST clients felt they
would struggle to talk to every female OST patient opportunistically
[TDF: Environmental context and resources].
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are busy but we still manage to carry out you know the services and stuff”
CP. 3.
8.2. Privacy
Most CPs emphasised that the provision of RH service should take place
in the consultation room to maintain privacy. However, in some pharma-
cies the consultation room was very small, far from the dispensary, used
for storage or discussion could be heard from outside [TDF: Environmental
context and resources]. In other pharmacies, OST patients had to access the
pharmacy from a different door with no access to the consultation room.
Others used a booth that was not considered sufficiently private. Addition-
ally, some pharmacists were concerned about being in an enclosed area
with someone from this patient group because of past negative experiences
[TDF: Beliefs about consequences].
“Most of them have opted to stay out there and just drink it or have it in front
of other people. There have been one or two patients who prefer more privacy,
so yes, they will come into the room and [I] supervise them... they were given
a choice” CP. 10.
8.3. Funding
CPs stated that the funding of a RH service would need to depend on
how extensive the service would be (e.g. brief advice versus clinical provi-
sion) and that it would vary according to local areas' needs. If the service
consisted of basic RH advice and referrals to other providers for contracep-
tion, pregnancy follow-up or terminations, thatwas seen as part of the phar-
macist's existing role [TDF: Social/professional role and identity].
However, if the service involved more tasks (e.g. prescribing oral contra-
ception, administrating other methods such as depot injections), then it
had to be funded as such [TDF: Reinforcement].
“In terms of the specialist thing that the pharmacist provide in general advice
is free basically you don't have to pay for it provided the service but if it's doing
anything an extra then I think in general think there might need funding for it
but all we can do is signpost to services available for them” CP. 13.
9. Discussion
The main aim of this paper was to provide insights into pharmacists'
views on the provision of a RH service to women receiving OST. We used
the TDF/COM-B (Fig. 1) to code the influences CPs described on the pro-
posed behaviour.18,20,21 Nine of the 14 TDF domains (knowledge; memory
attention and decision making; social /professional role and identity; be-
liefs about capabilities; beliefs about consequences; emotion; reinforce-
ment, social influences; environmental context and resources) were
identified and mapped to five of the six COM-B elements (Fig. 2).
The analysis approach adopted in this paper allowed for presenting the
identified TDF domains and the COM-B elements within a naturally occur-
ring inductive context and provided a better understanding to how these
factors affected each other (Fig. 3). For example, CPs' knowledge about the
topic represented part of their psychological capability and could influence
their beliefs about their capabilities. Knowledge gaps have been identified in
this study (OST effects on fertility, CPs' knowledge of the RH needs of
women receiving OST). An important observation was that most of CPs
were more comfortable if women receiving OST initiated the subject
(social opportunity) to which they would respond (automatic motivation).
When CPs realised that they had to initiate the conversation proactively,
CPs' thought processes shifted to their reflective motivation (beliefs about
their capabilities and beliefs about consequences). Another finding was that
many CPs emphasised the importance of determining the need for the ser-
vice for each individual (psychological capability [Memory, attention and de-
cision-making]).8
According to the Andersen healthcare utilization model,35 ‘need’ is one
of the main factors which lead to use of a healthcare service. In our study,
pharmacists talked about selectively offering the intervention, deciding
the need ‘on behalf of’ the patient. In the absence of a guideline, our data
suggest that some pharmacists may decide on such need (and what advice
to give) based on patients' characteristics such as age, marital status, known
sex work) and perceived social structure (e.g. if the woman is perceived as
capable of taking care of a child). This demonstrates there is a risk that
pharmacists would rely on stereotypical judgements about women to deter-
mine their need for RH advice, and subsequently lead to inequitable access
and stigma.
The findings also pointed to a power dynamic between the pharmacist
and all OST patients (not just female patients) and this influenced their in-
teractions. Power dynamics have been studied within a context of
physician-patient interaction.36,37 In the physicians' case, their power was
a result of them having a “cultural capital” (e.g. medical knowledge & skills)
or “symbolic capital” (e.g. accumulated professional prestige or honour)”. How-
ever, in the pharmacists' case, in addition to them having a cultural and
symbolic capital, the nature of the OST service gave an additional power
to the pharmacist which they identified (e.g. the pharmacist's ability to de-
cidewhether the patient can take the dose, where they should take it and to
refuse to dispense if patient does not comply).With the current emphasis on
patient-centeredness and what it means in terms of shared decision-making
and dialogue in a health care setting,35 the concept of patient-centeredness
seems out of reach in this context. In contrast, when other CPs described the
relationship with women as good, elements of empathy, trust and respect
were apparent in the approach they described for dealing with this patient
group. Empathy, trust, respect, and privacy are core pillars of good consul-
tation, and any future service needs to include these pillars in their
approach to consulting with women.38,3910. Limitations
One limitation of this study was that the data were collected between
Sept 2016 andMay 2017. However, the situation in the UK regardingmeet-
ing the RH needs of OST female patients remains unchanged. Our findings
cannot automatically be generalised to other countries and additional re-
search on the views and experiences of women in other settings would be
useful. The CPs responded to an invitation to participate in the study, and
therefore may have been more motivated towards the idea of providing
RH support for women. Despite this, our data suggests several pharmacists
were not motivated to provide this care and thus presenting a variety of
opinions.11. Conclusion
This study has identified a range of factors that could influence the pro-
vision of reproductive Health (RH) advice/service towomen receiving Opi-
oid Substitution Treatment. The study revealed the challenges pharmacists
perceived if required to proactively provide a reproductive Health (RH) ser-
vice, and their perception was subject to reflective motivation (their beliefs
about capabilities and consequences). The power dynamics between the
pharmacist and the women might act as a barrier to the delivery of the ser-
vice. The findings, although identified in the context of CPs' suggested pro-
vision of RH service to women receiving OST, can be extended to other
health care professionals in similar settings, i.e. providing a health care ad-
vice can be subjected to the healthcare professional's reflective thinking.
Any future RH service design needs to consider the factors identified in
this study.Funding
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